Key Points
- Insider Michael Rutz sold 150,000 Sotera Health shares at an average price of $18.84, totaling $2.826 million and reducing his ownership by 30.97% to 334,279 shares.
- Sotera Health exceeded quarterly expectations, reporting $0.26 EPS versus $0.24 expected and revenue of $321.38 million, up 9.2% year over year.
- Analyst sentiment remains favorable, with an average “Moderate Buy” rating and a $21.50 average price target; the stock recently traded at $19.11.
Sotera Health Company (NASDAQ:SHC - Get Free Report) insider Michael Rutz sold 150,000 shares of Sotera Health stock in a transaction on Friday, August 7th. The shares were sold at an average price of $18.84, for a total value of $2,826,000.00. Following the completion of the sale, the insider directly owned 334,279 shares of the company's stock, valued at $6,297,816.36. This trade represents a 30.97% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is accessible through the SEC website.
Sotera Health Trading Up 0.7%
SHC stock opened at $19.11 on Wednesday. The company has a quick ratio of 2.55, a current ratio of 2.80 and a debt-to-equity ratio of 3.33. Sotera Health Company has a twelve month low of $13.09 and a twelve month high of $19.85. The company has a market cap of $5.45 billion, a P/E ratio of 33.53 and a beta of 1.77. The business has a fifty day moving average of $17.28 and a 200-day moving average of $16.31.
Sotera Health (NASDAQ:SHC - Get Free Report) last posted its quarterly earnings results on Thursday, August 6th. The company reported $0.26 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.24 by $0.02. The business had revenue of $321.38 million for the quarter, compared to analysts' expectations of $309.70 million. Sotera Health had a return on equity of 40.12% and a net margin of 13.44%.The firm's quarterly revenue was up 9.2% compared to the same quarter last year. During the same quarter last year, the business earned $0.20 earnings per share. Sotera Health has set its FY 2026 guidance at 0.950-1.010 EPS. As a group, equities research analysts expect that Sotera Health Company will post 0.87 EPS for the current year.
Analyst Upgrades and Downgrades
Several equities research analysts have recently commented on the stock. Piper Sandler reiterated an "overweight" rating and set a $25.00 price target (up from $22.00) on shares of Sotera Health in a research report on Friday, August 7th. JPMorgan Chase & Co. lifted their target price on shares of Sotera Health from $16.00 to $18.00 and gave the stock a "neutral" rating in a report on Friday, August 7th. The Goldman Sachs Group began coverage on shares of Sotera Health in a research report on Friday, June 5th. They set a "buy" rating and a $20.00 target price for the company. UBS Group set a $19.00 price target on Sotera Health in a research note on Wednesday, June 24th. Finally, Weiss Ratings upgraded Sotera Health from a "hold (c-)" rating to a "hold (c)" rating in a research report on Thursday, July 9th. Eight analysts have rated the stock with a Buy rating and three have assigned a Hold rating to the company. According to data from MarketBeat, the stock currently has an average rating of "Moderate Buy" and an average price target of $21.50.
Read Our Latest Report on SHC
Institutional Trading of Sotera Health
Institutional investors and hedge funds have recently modified their holdings of the stock. IFP Advisors Inc boosted its stake in Sotera Health by 1,105.6% during the 4th quarter. IFP Advisors Inc now owns 1,495 shares of the company's stock worth $26,000 after acquiring an additional 1,371 shares during the last quarter. Rothschild Investment LLC bought a new stake in Sotera Health in the fourth quarter valued at approximately $27,000. Root Financial Partners LLC increased its stake in Sotera Health by 217.5% in the first quarter. Root Financial Partners LLC now owns 2,124 shares of the company's stock valued at $30,000 after purchasing an additional 1,455 shares in the last quarter. Meeder Asset Management Inc. acquired a new stake in Sotera Health in the second quarter worth $37,000. Finally, EverSource Wealth Advisors LLC raised its holdings in Sotera Health by 831.4% in the second quarter. EverSource Wealth Advisors LLC now owns 3,288 shares of the company's stock worth $37,000 after purchasing an additional 2,935 shares during the period. 91.03% of the stock is owned by institutional investors.
Sotera Health Company Profile
(
Get Free Report)
Sotera Health Inc (NASDAQ: SHC) is a global provider of sterilization and laboratory testing services that support the medical device, pharmaceutical, life sciences and consumer product industries. Headquartered in Jacksonville, Florida, the company offers a suite of services designed to ensure products meet rigorous safety and regulatory requirements before reaching market.
Sotera Health operates through three primary service platforms. Its Sterigenics division delivers contract sterilization solutions, including ethylene oxide (EtO), gamma irradiation, electron beam and X-ray technologies.
Featured Stories
This instant news alert was generated by narrative science technology and financial data from InsiderTrades.com in order to provide readers with the fastest and most accurate reporting. Please send any questions or comments about this story to [email protected].
